2m 2m 2m 2m 2m 2m 2m
- $9.0BMarket Cap
- 36.98%1-Year Change
- Medical DevicesIndustry
Globus Medical-A (GMED)
Key Performance
More- Earnings Score: 73
- Momentum Score: 61
- True Yield: N/A
- Financial Health Score: 84
Latest Research & News
The global spinal implants market was valued at USD 11.5 billion in 2024 and is projected to reach USD 15.8 billion by 2030, growing at a CAGR of 5.5%. Growth is driven by an aging global population, rising traumatic injuries, and advancements in minimally invasive spine surgery. Spinal fusion devices dominate the market, while Asia Pacific is expected to show the highest growth rate during the forecast period.
01/19/2026, 4:54 AM • GlobeNewswire
The global Pedicle Screw Systems Market is projected to grow from $2.38 billion in 2025 to $3.71 billion by 2033, with a 5.76% CAGR, driven by rising spinal disorder prevalence and technological advancements in spine surgery.
12/17/2025, 7:00 AM • GlobeNewswire
Multiple large-cap companies reported strong Q3 earnings and raised fiscal year guidance, leading to significant stock price gains across various sectors including technology, travel, and healthcare.
11/09/2025, 7:08 AM • Benzinga
Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025Â Sales Results
Globus Medical announced leadership transitions, with Keith Pfeil becoming President and CEO, replacing Dan Scavilla. Kyle Kline was appointed as the new CFO. The company reported preliminary Q2 2025 sales of $745.3 million, an 18.4% increase from the previous year.
07/21/2025, 8:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Key Executives
- David C. Paul
- Keith W. Pfeil
- Kelly G. Huller
- Kyle R. Klin
- Brian J. Kearns
Current Ownership Distribution
- Institutions1.7B (76.56%)
- Mutual Funds533.3M (23.40%)
- Insiders830,710 (0.04%)
- Other0 (0.00%)